It is stated right in the presentation yesterday. Give it a

New Post Public Reply Private Reply Replies (1) Message Board
TheProgressive Drano #11980
It is stated right in the presentation yesterday. Give it a listen when you ahve a chance:

http://www.media-server.com/m/p/ad4gm88c

Here is a nice recap from another poster on IHUB:

These are my notes from the audio presentation with timestamps and added links for additional information--I hope it helps some other investors out there...


KEVETRIN

- CTIX is currently recruiting for cohort 7
- (4:30) Even though patients with stage 4 cancers are expected to be able to take only one cycle of trial drugs, nearly all the patients in the Kevetrin trial have been able to take multiple cycles.
- (6:10) [Info on how many cycles each patient completed]
- (6:25) There is evidence of tumor regression. [ This must have occurred at or below 75mg/m2 dosage because the results for cohort 6, which was set at 110mg/m2, have not come back yet. ]
- There are three planned follow-on trials for Kevetrin:

1. (6:40) Acute & Chronic Myeloid Leukemia (Phase 1B) given with Cytarabine [ http://www.rxlist.com/cytarabine-drug.htm] in a new formulation at University of Bologna, Italy
2. (7:00) Drug resistant renal cancer cell line 786 (Phase 2) given with Sunitinib [ http://www.rxlist.com/sutent-drug.htm] at BIDMC
3. (7:40) “Another” phase 2 trial being planned for solid tumors…[ I wonder what this one is about?! ]


BRILACIDIN

- (11:05) Brilacidin is an immunomodulatory antimicrobial [ http://medical-dictionary.thefreedictionary.c...modulatory]
- There is nothing else out there like it
- It is bactericidal, anti-inflammatory, and anti-biofilm
- It restores and maintains “healthy barriers” in the body, i.e. skin and mucus membranes
- (12:20) It has the opportunity to be useful for bacterial, fungal, parasitic, and viral applications
- (12:35) It has the opportunity to be useful against inflammatory conditions that disrupt the barriers. Uses may include, but not limited to, oral mucositis, Inflammatory Bowel Disease , proctitis, dermatitis, acne, burns or abrasions. This may also extend to conditions affecting the membrane of the lungs such as respiratory mucosa, cystic fibrosis, and asthma.
- (14:05) There is a very low chance of resistance because Brilacidin mimics our own immune system
- (14:40) Brilacidin could have sub-MIC activity, which no other antibiotic has. It kills rapidly, lowering the chances of mutations. It also disrupts biofilms [ http://en.wikipedia.org/wiki/Biofilm] .
- (16:40) Comparing Brilacidin to Daptomycin [ http://www.rxlist.com/cubicin-drug.htm] , [brand name Cubicin] had approximately 8% of market sales totaling around $700 million in 2011, and those sales have now jumped up to close to a $1 billion. Brilacidin is estimated to take about $100 million.
- (1825) Some other uses may include diabetic foot infection, infective endocarditis [ http://www.mayoclinic.org/diseases-conditions...n-20022403] , and prosthetic joint infections [ http://www.uptodate.com/contents/treatment-of...infections] .
- (22:25) The FDA is very supportive of the planned Phase 2B single-dose trial where groups will be administered .6mg/kg for 1-day, .8mg/kg for 1-day, and then groups of 3-day dosings.


BRILACIDIN-OM

- Brilacidin for OM will be mixed with saline and water.
- (24:05) Kepivance [ http://www.rxlist.com/kepivance-drug.htm] , which is currently the only approved agent for use against OM costs $10,000 per cycle, and there are around 450,000 patients treated for OM each year in the U.S. alone. [ That’s a potential $4,500,000,000 market ]
- (25:40) Their plan for NDA approval: Phase 2 will be a Proof of Concept trial, and include about 60-120 patients. Phase 3 will include approximately 240 patients.
- (27:30) Cellceutix received proposals bids for formulation work, and a manufacturer needs to be selected still [ probably the “billion-dollar companies” CTIX has been talking to ]

So yes, Kevetrin has SHRUNK a tumor.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alabama Power's 2027 Cut Puts Data Centers to Work

Updated Category News Views 107

Data centers rarely arrive bearing a gift for ordinary power customers. Yet Alabama Power says its coming load growth will help cut customer rates by $160 million in 2027, beginning with January bills. In a utility world stuffed with requests for more money, that is a sharp change of pace. The company filed the reduction with the Alabama Public Service Commission on Nov....

Continue Reading
iHeart's 65% Plunge Brings a Fraud Probe Into Focus

Updated Category News Views 71

November 10 did not merely bruise iHeartMedia shareholders; it left the stock closing at $0.61 after a decline of more than 65%. That kind of move gets everybody’s attention, including plaintiffs’ lawyers, and Wolf Haldenstein Adler Freeman & Herz LLP has opened an investigation into potential securities fraud claims involving iHeartMedia, its officers, and its...

Continue Reading
Greenberg Traurig Adds Privacy Muscle in Denver Office

Updated Category News Views 147

Privacy work used to be the legal department's back-room plumbing; now it can jam an entire product launch. That is why Greenberg Traurig's decision to bring Amber Mednick in as of counsel in Denver deserves more attention than the usual law-firm hiring blurb. This is not a splashy deal, and nobody should pretend one lateral hire rewrites the competitive map. Still, it is...

Continue Reading
DISA Backs Nursing Education With OADN Foundation Push

Updated Category News Views 51

A nursing workforce does not appear by magic when hospitals need it most; somebody has to help students, instructors, and programs survive the long haul before that first shift. DISA's newly announced partnership with the Organization for Associate Degree Nursing and the OADN Foundation is aimed squarely at that unglamorous, essential stretch of the pipeline. For a sector...

Continue Reading
Maryland Handgun Ban Suit Puts Ruger in Legal Crossfire

Updated Category News Views 96

A January Deadline With Real Commercial Teeth Maryland has turned a trigger-design dispute into a fresh legal and retail headache, and the clock is not polite about it. The National Shooting Sports Foundation filed suit against the state over S.B. 334, which is scheduled to take effect Jan. 1, 2027. The law bars sales of certain pistols with cruciform trigger bars,...

Continue Reading
Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 84

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 39

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
GIGABYTE Pitches Local AI Agents to Enterprise Buyers

Updated Category News Views 72

Enterprise AI has reached the awkward stage where a slick chatbot demo no longer cuts it. GIGABYTE used its November 13 AI Partner Summit at the Pacific Palms Resort to make a more grounded pitch: companies need hardware and software setups that can put AI agents to work without casually tossing proprietary information into somebody else’s cloud. That is a sensible...

Continue Reading
New York Gala Puts $3 Million Behind EB Research Work

Updated Category News Views 67

Three million dollars changes the temperature in a research room, even if it does not magically solve the hard part. EB Research Partnership said its New York gala raised more than $3 million, with Eddie Vedder, Hozier, Tom Holland and Colin Farrell among the names helping draw attention. For a nonprofit operating around research, that is not a fluffy society-page...

Continue Reading
Avenir Nears 19.99% Grid Stake After Falcon West Resource

Updated Category News Views 76

Falcon West finally put enough geological meat on the bone to make Avenir reach for its wallet. Avenir Minerals expects to buy 29,388,127 Grid Metals common shares on or about November 30, 2026, taking its non-diluted position to 19.99%. That number is not accidental. It is the usual Canadian strategic-investor ceiling before the conversation starts getting considerably...

Continue Reading

Top 5 Most Recently Viewed Articles

CEO of Cogent Communications to Showcase Company Updates

Updated Category News Views 112

Cogent Communications' CEO Will Share Insights at Key Conferences Cogent Communications Holdings, Inc. (NASDAQ: CCOI), recognized as one of the world's premier Internet service providers, has exciting news to share. Dave Schaeffer, the Chief Executive Officer, is set to present at two significant upcoming conferences, demonstrating leadership in the connectivity space....

Continue Reading
AnteraCapital 365 Unmasked: The Truth Behind Fraudulent Claims

Updated Category News Views 338

Understanding the Fraud of AnteraCapital 365 Be an informed investor – protect yourself against fraudulent schemes. The Canadian Investment Regulatory Organization (CIRO) has issued a warning regarding AnteraCapital 365. This fraudulent firm operates on multiple websites claiming to be associated with legitimate organizations, specifically, SIG North Trading, ULC. It is...

Continue Reading
Understanding the Liberty Broadband and Charter Merger Insights

Updated Category News Views 309

Rowley Law PLLC Conducts Investigation into Liberty Broadband Recently, Rowley Law PLLC has announced an investigation related to proposed acquisition activities involving Liberty Broadband Corporation (NASDAQ: LBRDA). This scrutiny comes amid news that Charter Communications, Inc. (NASDAQ: CHTR) intends to acquire Liberty Broadband. This proposed merger is set to impact...

Continue Reading
C3.ai Investors Urged to Act Now for Class Action Lawsuit

Updated Category News Views 198

C3.ai Investors Face Class Action Lawsuit The recent developments regarding C3.ai, Inc. (NYSE: AI) are significant for investors who have faced substantial losses. The former Attorney General of Louisiana, Charles C. Foti, Jr., alongside Kahn Swick & Foti, LLC, has reached out to stakeholders, reminding them of an impending deadline related to a class action lawsuit....

Continue Reading
JW Michaels Shares Insights on Salary Trends in Finance

Updated Category News Views 311

Understanding Executive Compensation in Financial Services Every year, companies and organizations strive to understand the nuances of compensation within the financial sector. JW Michaels & Co. recently released its latest Financial Services Market Data Report, offering valuable insights into executive remuneration practices for top-tier positions. This comprehensive...

Continue Reading